Cargando…
Management preferences in stage I non-seminomatous germ cell tumours of the testis: an investigation among patients, controls and oncologists.
Increasingly, treatment choices leading to the same survival outcome can be offered to cancer patients (e.g. mastectomy or conservative surgery in early breast cancer). Two approaches available for post-orchidectomy, stage I patients with non-seminomatous germ cell tumours of the testis (NSGCTT), pa...
Autores principales: | Cullen, M. H., Billingham, L. J., Cook, J., Woodroffe, C. M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074781/ https://www.ncbi.nlm.nih.gov/pubmed/8912550 |
Ejemplares similares
-
Prognostic factors in clinical stage I non-seminomatous germ-cell tumours of the testis.
por: Raghavan, D., et al.
Publicado: (1982) -
Surveillance or etoposide-containing combination chemotherapy for stage I non-seminomatous germ cell tumours of the testis (NSGCTT)
por: Colls, B. M.
Publicado: (1994) -
Surgery in metastatic non-seminomatous germ cell tumours.
por: Tobias, J. S.
Publicado: (1992) -
Adjuvant bleomycin, vincristine and cisplatin (BOP) for high-risk stage I non-seminomatous germ cell tumours: a prospective trial (MRC TE17)
por: Dearnaley, D P, et al.
Publicado: (2005) -
Frequency of serum tumour marker monitoring in patients with non-seminomatous germ cell tumours.
por: Seckl, M. J., et al.
Publicado: (1990)